KM Research Hub
← 返回结果库查看论文详情PubMed ↗
READ-ONLY DIGITIZATION RESULT

Progression to Wheelchair in Secondary Progressive Multiple Sclerosis and Impact of Siponimod: Post Hoc Analyses From the EXPAND Study.

Eur J Neurol · 2026-Jun · PMID 42257510

Panel Progression_to_EDSS_7.0质量警告待 EXE 对齐验证

Progression to EDSS ≥ 7.0

FIGURE 1 Percentage of participants with progression to EDSS ≥ 7.0 sustained until last observation in the core part——while on treatment (WOT). In the derivation of the Cox regression and Kaplan–Meier estimates, data were re‐weighted using IPW, such that the proportion of participants in the following subgroups (baseline EDSS < 5.5, 5.5–6.0, 6.5) was balanced between siponimod and placebo, and matched that of the overall population. Numbers at risk are not adjusted. CI, confidence interval; EDSS, Expanded Disability Status Scale; HR, hazard ratio; IPW, inverse probability weighting; WOT, while on treatment.

算法:legacy-0.5.0引擎:enhanced-linux
质量评分0.58
质量通过否
预期曲线2
实际曲线1
X 范围-
Y 范围-

曲线数据

网页最多预览 200 行,完整数据请下载 CSV 或 JSON。

当前面板没有可预览的 `curves_mapped.csv` 数据。
历史版本(1)

重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。

版本状态验证曲线时间
legacy-0.5.0quality_warning待验证12026-07-23T16:47:29+00:00